EC Number |
Application |
Reference |
---|
3.4.23.34 | medicine |
antitumor activity of cathepsin E in human prostate carcinoma tumor cell lines |
679028 |
3.4.23.34 | medicine |
cathepsin E is a specific marker of dysplasia in APC(Min/+) mouse intestine. Potential utility for catE as a marker for the inception and progression of intestinal cancers |
670982 |
3.4.23.34 | medicine |
combination of cathepsin E and doxorubicin is sufficient to overcome resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in chemoresistant prostate cancer PPC-1 cells |
707628 |
3.4.23.34 | medicine |
pancreas-bearing pancreatic intraepithelial neoplasia lesions and pancreatic tumours show an elevated expression of cathepsin E, allowing selective in-vivo detection of human pancreatic ductal adenocarcinoma xenografts and imaging of pancreas with pancreatic intraepithelial neoplasia lesions and pancreatic tumours in genetically engineered mouse models of pancreatic cancer |
717647 |
3.4.23.34 | molecular biology |
CatE is a potential cancer biomarker |
679028 |
3.4.23.34 | more |
CatE is essential for processing of ovalbumin by murine B-cells, Cat E could play a major role in antigen processing, involvement of CatE in the MHC class II pathway |
677990 |